Pulmonx Corp (NAS:LUNG)

$ 8.07 -0.31 (-3.7%) Market Cap: 313.24 Mil Enterprise Value: 237.69 Mil PE Ratio: 0 PB Ratio: 2.83 GF Score: 61/100

Q1 2024 Pulmonx Corp Earnings Call Transcript
May 01, 2024

$7.72 (+1.45%)

Earnings
Q4 2023 Pulmonx Corp Earnings Call Transcript
Feb 21, 2024

$14.5 (+0.62%)

Earnings
Q3 2023 Pulmonx Corp Earnings Call Transcript
Oct 30, 2023

$7.89 (-4.01%)

Earnings
Q2 2023 Pulmonx Corp Earnings Call Transcript
Aug 02, 2023

$13.23 (-4.20%)

Earnings
Pulmonx Corp at Bank of America Global Healthcare Conference Transcript
May 09, 2023
Q1 2023 Pulmonx Corp Earnings Call Transcript
May 02, 2023

$11.47 (-6.90%)

Earnings
Pulmonx Corp at Citi Healthcare & Medtech Conference Transcript
Mar 02, 2023
Q4 2022 Pulmonx Corp Earnings Call Transcript
Feb 22, 2023

$8.76 (+0.46%)

Earnings
Q3 2022 Pulmonx Corp Earnings Call Transcript
Nov 03, 2022

$12.34 (-9.53%)

Earnings
Pulmonx Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Q2 2022 Pulmonx Corp Earnings Call Transcript
Aug 02, 2022

$18.48 (+5.60%)

Earnings
Pulmonx Corp at Bank of America Healthcare Conference Transcript
May 10, 2022
Q1 2022 Pulmonx Corp Earnings Call Transcript
May 03, 2022

$25.34 (+1.04%)

Earnings
Pulmonx Corp at Citi Healthcare Conference (Virtual) Transcript
Feb 24, 2022
Q4 2021 Pulmonx Corp Earnings Call Transcript
Feb 23, 2022

$26.25 (-2.56%)

Earnings
Pulmonx Corp at JPMorgan Healthcare Conference Transcript
Jan 11, 2022
Q3 2021 Pulmonx Corp Earnings Call Transcript
Nov 02, 2021

$39.72 (-0.80%)

Earnings
Pulmonx Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021
Q2 2021 Pulmonx Corp Earnings Call Transcript
Aug 03, 2021

$39.19 (-2.59%)

Earnings
Pulmonx Corp at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 11, 2021
Q1 2021 Pulmonx Corp Earnings Call Transcript
May 04, 2021

$46.88 (-0.45%)

Earnings
Q4 2020 Pulmonx Corp Earnings Call Transcript
Mar 02, 2021

$58.05 (-3.52%)

Earnings
Q3 2020 Pulmonx Corp Earnings Call Transcript
Nov 10, 2020

$46.33 (-3.70%)

Earnings

Pulmonx Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2022 / 12:30PM GMT

Release Date Price: $29.99 (-0.99%)

Transcript

Unidentified Analyst

Good morning, everyone, and welcome back to JPMorgan's 40th Annual Healthcare Conference. Very excited to have you all here this morning. I am thrilled to introduce Pulmonx to you this morning. Here we have Glen French, President and CEO, who's very excited to tell you a little bit more about their story. So I'll hand it off to you. Glen, thank you again for being here.

Glendon E. French

Pulmonx Corporation - CEO, President & Director

Lisa, thank you very much. And particularly given that you're in San Francisco, and it's 4:30 in the morning, thank you very much for being here, and I look forward to talking to everybody.

So the -- I'm here today to talk about Pulmonx. I'm the CEO of Pulmonx. I've been with the company for about 7 years and have been in this interventional pulmonology space for the better part of the last 25 years.

I'd like to -- as I move through this presentation, I will reference the slide numbers. My understanding is that everybody has the slides in front of them and can toggle through as we go.

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.